Wednesday, July 8, 2026

pharma · Melanoma · Alcohol Use Disorder · ADIL

ADIAL PHARMACEUTICALS

ADIAL PHARMACEUTICALS trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

CHARLOTTESVILLE, VA, ES HQ
2021 Founded
16 Employees
Public company Type
ADIL · NYSE Ticker
Company details
Intelligence · Clinical Trials

ADIAL PHARMACEUTICALS clinical trials

Registry index of 6 ClinicalTrials.gov studies linked to ADIAL PHARMACEUTICALS programs — each row shows trial ID, program name, phase, status, and indication.

ADIAL PHARMACEUTICALS trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for ADIAL PHARMACEUTICALS.

  1. Trametinib (GSK1120212) — Phase 2

    Clinical update
  2. Nizatidine — Phase 1

    Clinical update
  3. Axitinib — Phase 2

    Clinical update
  4. AD04 (ondansetron) — Phase 3

    Clinical update
  5. Erythromycin lactobionate — Phase 1

    Clinical update
  6. rhBMP-2 placement — Unknown

    Clinical update

Trial registry

6 studies